Castle Biosciences (CSTL) Capital Expenditures Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 50.00% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 3.87% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -3.27% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -72.44% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 1.48% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -33.33% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -10.56% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 18.75% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 0.92% |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn | 287.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 287.16% |
| Dec 31, 2025 | -28.73% |
| Sep 30, 2025 | 245.17% |
| Jun 30, 2025 | -73.65% |
| Mar 31, 2025 | 360.23% |
| Dec 31, 2024 | -647.30% |
| Sep 30, 2024 | -29.91% |
| Jun 30, 2024 | 624.21% |
| Mar 31, 2024 | -79.06% |
| Dec 31, 2023 | 254.88% |
| Sep 30, 2023 | 188.98% |
| Jun 30, 2023 | -493.07% |
| Mar 31, 2023 | 10,331.25% |
| Dec 31, 2022 | 91.75% |
| Jun 30, 2022 | -97.95% |
| Mar 31, 2022 | -95.73% |
| Dec 31, 2021 | -114,334.62% |
| Jun 30, 2021 | 1,747.04% |
| Mar 31, 2021 | 50.00% |
| Dec 31, 2020 | -92.51% |